Evidence map›Paper›PMID 31068478›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Reply to Liu et al.: ALK5-mediated tumor suppressor signaling through SMAD2 and SMAD3 in the uterus.

Diana Monsivais, Maya Kriseman, Chad J Creighton, Martin M Matzuk

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Diana MonsivaisDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030.
Maya KrisemanDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030.
Chad J CreightonDepartment of Medicine, Baylor College of Medicine, Houston, TX 77030.
Martin M MatzukDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030; mmatzuk@bcm.edu.
Baylor College of Medicine · US

Funding

Transforming growth factor β family signaling pathways in ovarian and uterine biologyR01HD032067 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI MARTIN M. MATZUK · 1994 to 2026
$9.9M
Research Education and Career Horizons ProgramK12GM084897 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI SIFERS, RICHARD NORMAN, SLAUGHTER, GAYLE · 2008 to 2016
$8.3M
REPRODUCTIVE FUNCTION USING TRANSGENIC MICER01HD033438 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI MATZUK, MARTIN M. · 1996 to 2015
$2.5M
The role of SMAD1 and SMAD5 in hormonal response, endometrial receptivity and glandular functionK99HD096057 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI MONSIVAIS, DIANA · 2018 to 2019
$260k
NICHD NIH HHS K99 HD096057NICHD NIH HHS R01 HD032067NICHD NIH HHS R01 HD033438NIGMS NIH HHS K12 GM084897
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Endometrial NeoplasmsSignal TransductionFemaleHumansSmad2 ProteinSmad3 ProteinTransforming Growth Factor betaSmad2 ProteinSMAD2 protein, humanSmad3 ProteinSMAD3 protein, humanTransforming Growth Factor beta

Identifiers

PMID31068478
PMCPMC6511039
OpenAlexW2944068832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.